6.
Zhu Q, Li Y, Ma J, Ma H, Liang X
. Potential factors result in diminished ovarian reserve: a comprehensive review. J Ovarian Res. 2023; 16(1):208.
PMC: 10598941.
DOI: 10.1186/s13048-023-01296-x.
View
7.
Sutherland R, Prall O, Watts C, Musgrove E
. Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia. 2000; 3(1):63-72.
DOI: 10.1023/a:1018774302092.
View
8.
Joshi H, Hill H, Asch J, Margraf R, Coonrod E, Durtschi J
. CXXC5 variant in an immunodeficient patient with a progressive loss of hematopoietic cells. J Allergy Clin Immunol. 2020; 147(4):1504-1507.e8.
DOI: 10.1016/j.jaci.2020.09.036.
View
9.
Song H, Hong S, Kim T, Kim D
. Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy. PLoS One. 2012; 7(4):e35552.
PMC: 3327670.
DOI: 10.1371/journal.pone.0035552.
View
10.
Pendino F, Nguyen E, Jonassen I, Dysvik B, Azouz A, Lanotte M
. Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis. Blood. 2009; 113(14):3172-81.
DOI: 10.1182/blood-2008-07-170035.
View
11.
He Y, Wei T, Ye Z, Orme J, Lin D, Sheng H
. A noncanonical AR addiction drives enzalutamide resistance in prostate cancer. Nat Commun. 2021; 12(1):1521.
PMC: 7943793.
DOI: 10.1038/s41467-021-21860-7.
View
12.
Kim E, Seo S, Hwang Y, Ryu Y, Kim H, Lee K
. Inhibiting the cytosolic function of CXXC5 accelerates diabetic wound healing by enhancing angiogenesis and skin repair. Exp Mol Med. 2023; 55(8):1770-1782.
PMC: 10474114.
DOI: 10.1038/s12276-023-01064-3.
View
13.
Canalis E, Giustina A, Bilezikian J
. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007; 357(9):905-16.
DOI: 10.1056/NEJMra067395.
View
14.
Ayaz G, Razizadeh N, Yasar P, Kars G, Kahraman D, Saatci O
. CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation. Sci Rep. 2020; 10(1):5971.
PMC: 7136269.
DOI: 10.1038/s41598-020-62912-0.
View
15.
Wu M, Chen G, Li Y
. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016; 4:16009.
PMC: 4985055.
DOI: 10.1038/boneres.2016.9.
View
16.
Ma S, Choi J, Jin X, Kim H, Yun J, Lee W
. Discovery of a small-molecule inhibitor of Dvl-CXXC5 interaction by computational approaches. J Comput Aided Mol Des. 2018; 32(5):643-655.
DOI: 10.1007/s10822-018-0118-x.
View
17.
Lee S, Seo S, Lee D, Pi L, Lee W, Choi K
. Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. J Invest Dermatol. 2017; 137(11):2260-2269.
DOI: 10.1016/j.jid.2017.04.038.
View
18.
Marttila S, Kananen L, Jylhava J, Nevalainen T, Hervonen A, Jylha M
. Length of paternal lifespan is manifested in the DNA methylome of their nonagenarian progeny. Oncotarget. 2015; 6(31):30557-67.
PMC: 4741551.
DOI: 10.18632/oncotarget.5905.
View
19.
Barros-Filho M, Barreto Menezes de Lima L, Dos Reis M, de Mello J, Beltrami C, Pinto C
. Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas. Int J Mol Sci. 2019; 20(6).
PMC: 6471408.
DOI: 10.3390/ijms20061334.
View
20.
Juszczak G, Stankiewicz A
. Glucocorticoids, genes and brain function. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 82:136-168.
DOI: 10.1016/j.pnpbp.2017.11.020.
View